Genome Editing Market
Updated Date: 08 July 2026   |   Report Code: 5161
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Genome Editing Market Growth, Innovations, and Market Size Forecast 2035

According to Shivani Zoting, who specializes in genomics, biotechnology, and precision medicine, with 5+ years of experience in market research and industry analysis, this research highlights strong long-term growth in the genome editing market, which is projected to expand from USD 10.98 billion in 2025 to USD 52.56 billion by 2035 at a 16.95% CAGR. Her analysis identifies genetic engineering, CRISPR/Cas9 technology, ex-vivo delivery methods, and biotechnology & pharmaceutical companies as the market's leading segments, while North America maintains its leadership and Asia Pacific records the fastest growth. She also examines how innovation and strategic initiatives from companies such as Thermo Fisher Scientific, Lonza, Danaher, CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Takara Bio, and Merck KGaA continue to shape the competitive landscape.

Last Updated : 08 July 2026 Category: Biotechnology Insight Code: 5161 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Genome Editing Market Assessment

  • Overview
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations
  • Global Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

North America Genome Editing Market Assessment

  • Overview
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • North America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Europe Genome Editing Market Assessment

  • Overview
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Europe Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Asia Pacific Genome Editing Market Assessment

  • Overview
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Asia Pacific Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Latin America Genome Editing Market Assessment

  • Overview
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • Latin America Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

MEA Genome Editing Market Assessment

  • Overview
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Genetic Engineering
      • Cell Line Engineering
      • Animal Genetic Engineering
      • Plant Genetic Engineering
      • Others
    • Clinical Applications
      • Diagnostics
      • Therapy Development
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • (CRISPR)/Cas9
    • TALENs/MegaTALs
    • ZFN
    • Meganuclease
    • Others
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • Ex-vivo
    • In-vivo
  • MEA Genome Editing Market Size Value (US$) and Volume (Billion Tons), by End-use (2021 – 2033)
    • Biotechnology and Pharmaceutical Companies
    • Academic and Government Research Institutes
    • Contract Research Organizations

Company Profiles

  • Thermo Fisher Scientific, Inc
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Lonza
  • Bluebird Bio, Inc.
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Genscript Biotech Corp
  • Transposagen Biopharmaceuticals, Inc.
  • Danaher Corporation
  • Horizon Discovery Ltd. (Revvity, Inc.)
  • Takara Bio Inc.
  • AstraZeneca
  • Cellectis S.A.
  • Caribou Biosciences, Inc
  • Intellia Therapeutics, Inc.
  • CRISPR Therapeutics
  • Precision BioSciences
  • Editas Medicine
  • Sangamo Therapeutics
  • Recombinetics
  • Cibus Inc.
  • Merck KGaA

Conclusion & Recommendations

FAQ's

Answer : The genome editing market is on a fast track expected to cross USD 12.84 billion in 2026 and surge to USD 52.56 billion by 2035, growing at a strong 16.95% CAGR

Answer : Three big trends stand out- CRISPR dominance, AI-driven gene design, and in-vivo delivery growth.

Answer : World Health Organization, National Heart, Lung, and Blood Institute, FDA, The White House, USAD, Press Information Bureau.
Any Questions

Meet the Team

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar